111 related articles for article (PubMed ID: 10854614)
1. Early HIV infection in vivo: branching-process model for studying timing of immune responses and drug therapy.
Wick D; Self SG
Math Biosci; 2000 Jun; 165(2):115-34. PubMed ID: 10854614
[TBL] [Abstract][Full Text] [Related]
2. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
[TBL] [Abstract][Full Text] [Related]
3. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.
Tsai CC; Follis KE; Sabo A; Beck TW; Grant RF; Bischofberger N; Benveniste RE; Black R
Science; 1995 Nov; 270(5239):1197-9. PubMed ID: 7502044
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques.
Rosenwirth B; ten Haaft P; Bogers WM; Nieuwenhuis IG; Niphuis H; Kuhn EM; Bischofberger N; Heeney JL; Uberla K
J Virol; 2000 Feb; 74(4):1704-11. PubMed ID: 10644340
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.
Van Rompay KK; Miller MD; Marthas ML; Margot NA; Dailey PJ; Canfield DR; Tarara RP; Cherrington JM; Aguirre NL; Bischofberger N; Pedersen NC
J Virol; 2000 Feb; 74(4):1767-74. PubMed ID: 10644348
[TBL] [Abstract][Full Text] [Related]
6. Control of SIV rebound through structured treatment interruptions during early infection.
Lori F; Lewis MG; Xu J; Varga G; Zinn DE; Crabbs C; Wagner W; Greenhouse J; Silvera P; Yalley-Ogunro J; Tinelli C; Lisziewicz J
Science; 2000 Nov; 290(5496):1591-3. PubMed ID: 11090360
[TBL] [Abstract][Full Text] [Related]
7. 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA.
Van Rompay KK; Cherrington JM; Marthas ML; Lamy PD; Dailey PJ; Canfield DR; Tarara RP; Bischofberger N; Pedersen NC
Antimicrob Agents Chemother; 1999 Apr; 43(4):802-12. PubMed ID: 10103184
[TBL] [Abstract][Full Text] [Related]
8. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
Kumar A; Buch S; Foresman L; Bischofberger N; Lifson JD; Narayan O
Virology; 2001 Jan; 279(1):97-108. PubMed ID: 11145893
[TBL] [Abstract][Full Text] [Related]
9. Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques.
van Rompay KK; Dailey PJ; Tarara RP; Canfield DR; Aguirre NL; Cherrington JM; Lamy PD; Bischofberger N; Pedersen NC; Marthas ML
J Virol; 1999 Apr; 73(4):2947-55. PubMed ID: 10074144
[TBL] [Abstract][Full Text] [Related]
10. Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.
Van Rompay KK; Berardi CJ; Aguirre NL; Bischofberger N; Lietman PS; Pedersen NC; Marthas ML
AIDS; 1998 Jun; 12(9):F79-83. PubMed ID: 9662190
[TBL] [Abstract][Full Text] [Related]
11. Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques.
Silvera P; Racz P; Racz K; Bischofberger N; Crabbs C; Yalley-Ogunro J; Greenhouse J; Jiang JB; Lewis MG
AIDS Res Hum Retroviruses; 2000 May; 16(8):791-800. PubMed ID: 10826485
[TBL] [Abstract][Full Text] [Related]
12. AIDS research. New drug shows promise in monkeys.
Cohen J
Science; 1995 Nov; 270(5239):1121-2. PubMed ID: 7502035
[No Abstract] [Full Text] [Related]
13. An anti-HIV strategy combining chemotherapy and therapeutic vaccination.
Rosenwirth B; Bogers WM; Nieuwenhuis IG; Haaft PT; Niphuis H; Kuhn EM; Bischofberger N; Erfle V; Sutter G; Berglund P; Liljestrom P; Uberla K; Heeney JL
J Med Primatol; 1999; 28(4-5):195-205. PubMed ID: 10593486
[TBL] [Abstract][Full Text] [Related]
14. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.
Van Rompay KK; Johnson JA; Blackwood EJ; Singh RP; Lipscomb J; Matthews TB; Marthas ML; Pedersen NC; Bischofberger N; Heneine W; North TW
Retrovirology; 2007 Apr; 4():25. PubMed ID: 17417971
[TBL] [Abstract][Full Text] [Related]
15. The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy.
Clements JE; Li M; Gama L; Bullock B; Carruth LM; Mankowski JL; Zink MC
J Neurovirol; 2005 Apr; 11(2):180-9. PubMed ID: 16036796
[TBL] [Abstract][Full Text] [Related]
16. DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued.
Fuller DH; Rajakumar PA; Wu MS; McMahon CW; Shipley T; Fuller JT; Bazmi A; Trichel AM; Allen TM; Mothe B; Haynes JR; Watkins DI; Murphey-Corb M
Virology; 2006 Apr; 348(1):200-15. PubMed ID: 16439000
[TBL] [Abstract][Full Text] [Related]
17. CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment.
Van Rompay KK; Singh RP; Pahar B; Sodora DL; Wingfield C; Lawson JR; Marthas ML; Bischofberger N
J Virol; 2004 May; 78(10):5324-37. PubMed ID: 15113912
[TBL] [Abstract][Full Text] [Related]
18. Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis.
Curtis KA; Kennedy MS; Luckay A; Cong ME; Youngpairoj AS; Zheng Q; Smith J; Hanson D; Heneine W; Owen SM; García-Lerma JG
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):355-62. PubMed ID: 21637113
[TBL] [Abstract][Full Text] [Related]
19. Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.
Tarantal AF; Marthas ML; Shaw JP; Cundy K; Bischofberger N
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(4):323-33. PubMed ID: 10096575
[TBL] [Abstract][Full Text] [Related]
20. The clinical benefits of tenofovir for simian immunodeficiency virus-infected macaques are larger than predicted by its effects on standard viral and immunologic parameters.
Van Rompay KK; Singh RP; Brignolo LL; Lawson JR; Schmidt KA; Pahar B; Canfield DR; Tarara RP; Sodora DL; Bischofberger N; Marthas ML
J Acquir Immune Defic Syndr; 2004 Aug; 36(4):900-14. PubMed ID: 15220696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
